- Trials with a EudraCT protocol (272)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (834)
272 result(s) found for: CRO.
Displaying page 1 of 14.
EudraCT Number: 2021-003616-10 | Sponsor Protocol Number: ITM202101 | Start Date*: 2021-11-04 | |||||||||||
Sponsor Name:Institute of Tropical Medicine | |||||||||||||
Full Title: An open label randomized controlled trial comparing the effect of ceftriaxone plus azithromycin versus ceftriaxone for the treatment of Neisseria gonorrhoeae on the resistome | |||||||||||||
Medical condition: Neisseria gonorrhoeae (Ng) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003653-42 | Sponsor Protocol Number: CRO-2017-34 | Start Date*: 2018-11-20 | |||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO | |||||||||||||
Full Title: Phase II study to assess efficacy and safety of metronomic oral Idarubicin in patients with hepatocarcinoma at intermediate-advanced stage after failure or intolerance to Sorafenib and Regorafenib | |||||||||||||
Medical condition: Patients with interemdiate-advanced stage hepatocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-006072-32 | Sponsor Protocol Number: 2019/ABM/01/00078 | Start Date*: 2022-10-05 | |||||||||||
Sponsor Name:University Hospital in Poznań | |||||||||||||
Full Title: Pulmonary REsistance modification under treatment with Sacubitil/valsartaN in paTients with HeartFailure with reduced ejection fraction | |||||||||||||
Medical condition: Heart Failure with reduced ejection fraction. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002469-37 | Sponsor Protocol Number: CRO-2012-17 | Start Date*: 2012-09-28 | |||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO | |||||||||||||
Full Title: Phase II clinical study on the efficacy and safety of procedural analgesia of oral transmucosal fentanyl citrate in oncologic patients eligible to permanent central venous catheter | |||||||||||||
Medical condition: Cancer patients eligible to permanent central venous catheter due to chemotherapeutic treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004401-26 | Sponsor Protocol Number: CT-830-04-0004 | Start Date*: 2005-03-21 |
Sponsor Name:STADA R&D GmbH | ||
Full Title: Evaluation of the Safety of a Formulation Containing Epoetin (Epoetin STADA) Administered Intravenously for the Maintenance Treatment of Renal Anemia: an Open Follow-up Trial. Study code (CRO) 411-... | ||
Medical condition: Anemia caused by terminal renal insufficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003997-33 | Sponsor Protocol Number: NOAH-AFNET6 | Start Date*: 2016-11-18 | |||||||||||
Sponsor Name:Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork] | |||||||||||||
Full Title: Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes | |||||||||||||
Medical condition: Atrial fibrillation (AF) is one cause of stroke. Stroke rate is increased in patients with atrial high rate episodes (AHRE, an early stage of AF) as well, even if stroke rates are lower when compa... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) AT (Prematurely Ended) NL (Prematurely Ended) BG (Completed) SE (Prematurely Ended) PL (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) PT (Prematurely Ended) GR (Completed) DK (Prematurely Ended) IT (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001995-20 | Sponsor Protocol Number: 2205p | Start Date*: 2011-03-14 |
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | ||
Full Title: A pilot study on educational aproach to improve compliance to medical precriptions in transplantation recipients. | ||
Medical condition: Patients who underwent liver or renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005882-37 | Sponsor Protocol Number: 524 | Start Date*: 2008-01-17 | |||||||||||
Sponsor Name:BAUSCH&LOMB | |||||||||||||
Full Title: RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF 0.4% HYALURONIC ACID HYPOTONIC EYE DROPS (IALUREX) VS. HYDROXYPROPYL-GUAR EYE DROPS (SYSTANE) IN THE TREATMENT OF DRY EYE SY... | |||||||||||||
Medical condition: Dry eye syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000438-38 | Sponsor Protocol Number: CRO 682 | Start Date*: 2007-04-12 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Efficacy of Lopinavir in Pregnancy: Pharmacokinetic and Virological Studies with Kaletra melt extruded tablet formulation | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001472-18 | Sponsor Protocol Number: UDT-2/PHT | Start Date*: 2011-05-10 |
Sponsor Name:STZ 1172 Gesundheitsförderung und Stoffwechselforschung | ||
Full Title: Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension | ||
Medical condition: Portal hypertension, liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004746-28 | Sponsor Protocol Number: POR-TAP-16-007 | Start Date*: 2017-10-05 | |||||||||||
Sponsor Name:UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI | |||||||||||||
Full Title: Ticagrelor And PrEconditioning in patients with stable coronaRy artery diSease: a randomized pilot trial (TAPER-S trial) | |||||||||||||
Medical condition: Patients with multivessel coronary artery disease requiring staged, ischemia-guided PCI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003311-19 | Sponsor Protocol Number: AIH-MAB | Start Date*: 2018-01-09 |
Sponsor Name:University Medical Centre Hamburg-Eppendorf | ||
Full Title: Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using infliximab AIH-MAB | ||
Medical condition: Autoimmune Hepatitis (AIH); rare inflammatory liver disease associated with elevated transaminases, elevated Immunoglobulin G, the presence of autoantibodies and interface hepatitis in liver histol... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002728-35 | Sponsor Protocol Number: HUN-AVI-01 | Start Date*: 2020-09-17 | |||||||||||
Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium | |||||||||||||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia − An open-label randomized controlled study − | |||||||||||||
Medical condition: Patients with new type of coronavirus (SARS-CoV-2) infection proven by RT-PCR test with mild pneumonia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004928-42 | Sponsor Protocol Number: REM-ENY-01 | Start Date*: 2020-10-12 | |||||||||||
Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium | |||||||||||||
Full Title: Open-label study to assess the safety of REMdesivir-HU as Eligible Novel therapY for moderate and severe Covid-19 patients | |||||||||||||
Medical condition: SARS-CoV-2 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000409-35 | Sponsor Protocol Number: 1069_OPBG_2016 | Start Date*: 2016-05-13 |
Sponsor Name:Bambino Gesù Children's Hospital | ||
Full Title: Explorative study on the clinical efficacy and tolerability of methylprednisolone aceponate cream and a new topical medical device in paediatric patients with mild to moderate Atopic Dermatitis, t... | ||
Medical condition: Atopic Dermatitis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000487-28 | Sponsor Protocol Number: PROTECTION | Start Date*: 2018-08-06 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: Intravenous amino acid therapy for kidney protection in cardiac surgery: a multi-centre randomised blinded placebo controlled clinical trial | |||||||||||||
Medical condition: Patients undergoing cardiac surgery at risk for developing acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000224-10 | Sponsor Protocol Number: PBKV.5zdnia03.08.2022 | Start Date*: 2023-08-17 |
Sponsor Name:The Pharmaceutical Company LEK-AM Sp. Zo.o. | ||
Full Title: A randomized, double-blind, placebo-controlled, multicentre study to evaluate the effect of a 12-week dose of 35 mg DHEA on quality of life in menopausal women. | ||
Medical condition: Menopause | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: PL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-004160-16 | Sponsor Protocol Number: PBKV.8zdnia01.06.2022 | Start Date*: 2024-02-22 |
Sponsor Name:The Pharmaceutical Company LEK-AM Sp. Zoo. | ||
Full Title: A randomized, double-blind, placebo-controlled, multicenter study evaluating the effect of a 12-week DHEA combination of 20 mg and 2 mg prolonged-release melatonin on sleep quality an... | ||
Medical condition: Menopause, sleep disorders in the postmenopausal period | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: PL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001582-33 | Sponsor Protocol Number: Er-01-Perf-Stroke | Start Date*: 2012-09-19 |
Sponsor Name:University Hospital Erlangen | ||
Full Title: Intraindividual cross-over comparison of Gadobutrol and Gadoterate enhanced combined DSC-MR-Perfusion and MR-Angiography in patients with cerebrovascular disease | ||
Medical condition: Patients with high grade carotid artery stenosis or acute cerebral ischemia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003733-34 | Sponsor Protocol Number: APIDR_L_05719 | Start Date*: 2011-09-13 | |||||||||||
Sponsor Name:ikfe – Institute for Clinical Research and Development | |||||||||||||
Full Title: Human Insulin Analogs: Evaluation of inflammatory mRNA expression of Macrophages and Endothelial function of Short-acting insulin – HERMES Pilot Study | |||||||||||||
Medical condition: Patients with Diabetes mellitus Type 2 and a stable basal supported oral therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
